Healthcare Sector Attention Seeking Stocks: DaVita HealthCare Partners Inc (DVA), Idera Pharmaceuticals Inc (IDRA)


DaVita HealthCare Partners Inc (NYSE:DVA):

Stock’s Trading Stats:

DaVita HealthCare Partners Inc (NYSE:DVA) surged 0.60% Friday and closed at $74.90. The company’s market capitalization is at $15.53 billion with an average trading volume of 865,974.00. The total number of Outstanding Shares Held by the company are 209.75 Million.

Recent Press Release:

DaVita HealthCare Partners Inc. (DVA) on April 8, 2016 declared the company’s intent to acquire Mountain View Medical Group, a leading independent physician group in Colorado Springs. Under the proposal, Mountain View Medical Group would join the company’s HealthCare Partners division. Financial terms were not revealed.

Mountain View Medical Group is the second largest independent physician group in Colorado Springs with 50 physicians providing services counting family medicine, internal medicine, neurology, OB-GYN, pediatrics and podiatry. The group operates 14 medical office locations caring for more than 80,000 patients.

The transaction is predictable to close in July 2016, subject to negotiation of a final definitive agreement with Mountain View Medical Group, their shareholders’ approval of the transaction, regulatory approvals, completion of due diligence and other customary closing conditions.

Mountain View Medical Group (MVMG), located in Colorado Springs, Colorado, is a team of professional medical caregivers established at 14 different facilities throughout the Pikes Peak region but with one common aim… “Excellence Inspired by Compassion”. MVMG encompasses a spectrum of modalities from family medicine, internal medicine, neurology, OB/GYN, pediatrics and podiatry. The mission of everyone in the organization, counting each of the 71 highly qualified Colorado Springs clinicians, is to enhance the health and lives of over 80,000 MVMG patients and their families. For more information, please visit

Idera Pharmaceuticals Inc (NASDAQ:IDRA):

Stock’s Trading Stats:

Idera Pharmaceuticals Inc (NASDAQ:IDRA) closed at $1.79 Friday by showing a decrease of -1.65%. The total number of outstanding shares held by the company are 121.28 Million with the total market capitalization of $213.51 Million. The number of shares traded on the last trading session are 1.57 Million.

Recent Press Release:

Idera Pharmaceuticals, Inc. (IDRA) on April 11, 2016 declared that Idera’s Chief Executive Officer, Vincent Milano will present at the 15th Annual Needham Healthcare Conference on Tuesday, April 12, 2016 at 3:40 p.m. Eastern Time at the Westin Grand Central Hotel in New York City.

Live audio webcast of Idera’s presentations will be accessible in the Investors and Media section of Idera’s website at  Archived versions will also be accessible on the Company’s website after the event for 90 days.

Idera Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel nucleic acid-based therapies for the treatment of certain cancers and rare diseases. Idera’s proprietary technology involves using a TLR-targeting technology, to design synthetic oligonucleotide-based drug candidates to act by modulating the activity of specific TLRs. In addition to its TLR programs, Idera has created a third generation antisense technology platform using its proprietary technology to inhibit the production of disease-associated proteins by targeting RNA. To learn more about Idera, visit